Market Prospect and Two Major Competitors. Going by a Mordor Intelligence report, the CGM market is set to increase from $11.63 billion in 2024 to $21.34 billion by 2029, at a CAGR of 12.9%.

With the FDA approval of a new continuous glucose monitoring system with machine learning capabilities to predict highs and lows in blood-glucose levels, Medtronic makes a bigger play for type 2 ...

Latest approval expands Medtronic CGM portfolio in the U.S. GALWAY, Ireland, April 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced ...

The sensor is half the size of Medtronic’s last CGM, the Guardian 4, while also being easier to apply than its predecessor—via a two-step insertion process, using the included applicator tool ...

Medtronic is also developing its next-generation CGM sensors, stepping up the game from its original Enlite sensors and current Guardian 3 version that comes along with the Minimed 670G and stand ...

The CGM sensor, which is being developed by Abbott to work exclusively with Medtronic devices, will be sold by the latter. AID systems are beneficial for individuals with both type 1 and type 2 ...

Medtronic will begin a phased launch at the European Association for the Study of Diabetes 59th Annual Meeting in Hamburg, Germany on Oct. 2-6, 2023. Sandra Schlüter, Endocrinologist, Germany ...

Our test drive compares the new Medtronic Minimed Connect data-viewing mobile health app with Enlite CGM sensor to the similar Dexcom G4 system.

Medtronic has announced FDA approval of the Enlite sensor with iPro2 Professional Continuous Glucose Monitoring (CGM) system.. The sensor is a disposable glucose sensor. It provides the user with ...

Medtronic has made headlines for its advanced MiniMed 670G insulin pump, which reads data from Medtronic's disposable, body-worn Guardian Connect sensor to automatically decide whether to adjust a ...

Medtronic MDT recently announced two major developments within its diabetes care business. The company received FDA approval for its Simplera continuous glucose monitor (CGM), which marks a ...